- Home
- TSAT vs ESPR Comparison
TSAT vs ESPR Comparison
Compare TSAT & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- ESPR
- Stock Information
- Founded
- TSAT 1969
- ESPR 2008
- Country
- TSAT Canada
- ESPR United States
- Employees
- TSAT N/A
- ESPR N/A
- Industry
- TSAT Metal Fabrications
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- TSAT Industrials
- ESPR Health Care
- Exchange
- TSAT Nasdaq
- ESPR Nasdaq
- Market Cap
- TSAT 233.1M
- ESPR 208.1M
- IPO Year
- TSAT 1996
- ESPR 2013
- Fundamental
- Price
- TSAT $24.53
- ESPR $1.01
- Analyst Decision
- TSAT
- ESPR Buy
- Analyst Count
- TSAT 0
- ESPR 7
- Target Price
- TSAT N/A
- ESPR $5.93
- AVG Volume (30 Days)
- TSAT 143.8K
- ESPR 3.5M
- Earning Date
- TSAT 08-13-2025
- ESPR 08-11-2025
- Dividend Yield
- TSAT N/A
- ESPR N/A
- EPS Growth
- TSAT N/A
- ESPR N/A
- EPS
- TSAT N/A
- ESPR N/A
- Revenue
- TSAT $372,642,710.00
- ESPR $259,574,000.00
- Revenue This Year
- TSAT N/A
- ESPR $4.07
- Revenue Next Year
- TSAT N/A
- ESPR N/A
- P/E Ratio
- TSAT N/A
- ESPR N/A
- Revenue Growth
- TSAT N/A
- ESPR 12.99
- 52 Week Low
- TSAT $7.21
- ESPR $0.69
- 52 Week High
- TSAT $26.07
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- TSAT 71.52
- ESPR 46.78
- Support Level
- TSAT $22.35
- ESPR $0.99
- Resistance Level
- TSAT $26.07
- ESPR $1.10
- Average True Range (ATR)
- TSAT 1.73
- ESPR 0.07
- MACD
- TSAT 0.84
- ESPR -0.02
- Stochastic Oscillator
- TSAT 84.58
- ESPR 10.71
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.